Navigation Links
Siteman Cancer Center Treats First Patient With First-of-Its-Kind Proton Therapy System
Date:12/19/2013

St. Louis (PRWEB) December 19, 2013

A 33-year-old man from Leasburg, Mo., is the first patient to receive a revolutionary form of highly accurate radiation treatment from the world’s first proton system of its kind. The treatment was administered today at the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis.

Steven Osborne has a rare type of cancer called chondrosarcoma at the base of his skull. He will undergo a 30- to 45-minute session each weekday for the next seven weeks as the first patient of the S. Lee Kling Proton Therapy Center at Washington University Medical Center.

The S. Lee Kling Proton Therapy Center provides proton therapy to adult patients of the Siteman Cancer Center and pediatric patients of St. Louis Children’s Hospital. Patients eligible for the therapy have cancer near vital organs such as the spine, brain, heart and eyes.

“Proton therapy is unique because it allows for very precise adjustments to the radiation beam, so we can precisely target tumors,” said Jeffrey D. Bradley, MD, director of the Proton Therapy Center. “It helps to minimize damage to surrounding tissue and is especially useful when treating growing children.”

For example, treatment of a brain tumor such as Osborne’s with proton therapy may be less likely to result in blindness or other complications, said Bradley, who also is the S. Lee Kling Professor of Radiation Oncology at Washington University.

A superconducting synchrocyclotron proton accelerator is a key component of the new proton therapy system. The relatively small size of the device allows it to fit in a single room that isn’t much larger than a traditional radiation therapy room. Watch a video about the technology: http://goo.gl/WnO5LE. The cost of this single-vault proton therapy system was about $20 million. That represents a fraction of the investment needed for traditional proton therapy systems, which typically are housed in football field-sized buildings and cost in excess of $150 million.

“Our team of Washington University radiation oncologists and physicists has been instrumental in developing treatment planning and quality assurance processes for this technology,” Bradley said. “We’re now focused on using it to provide the best possible care for our patients.”

The S. Lee Kling Proton Therapy Center plans to treat 20 to 25 patients a day. Treatment will typically require daily 30-minute sessions for two months. The center will serve the region and the Midwest. The next closest location offering proton therapy is 225 miles away.

“The Siteman Cancer Center is pleased to be able to provide this new type of proton therapy,” said Timothy J. Eberlein, MD, Siteman’s director. “As partners in the development of this technology, we are translating cutting-edge science into better treatment options for our patients.”

The Proton Therapy Center was named after S. Lee Kling, a visionary St. Louisan who had to travel to the East Coast to receive proton therapy for an eye tumor. Kling, the former chairman of The Foundation for Barnes-Jewish Hospital’s board of directors, believed the therapy should be more accessible and available to patients in the area. His efforts helped raise $2.3 million through The Foundation’s illumination gala to fund research and the construction of a proton therapy facility.

The MEVION S250 Proton Therapy System was developed and manufactured by Littleton, Mass.-based Mevion Medical Systems with the assistance of radiation oncologists and physicists at Washington University in St. Louis.

###

About the Siteman Cancer Center
The Siteman Cancer Center, the only National Cancer Institute-designated Comprehensive Cancer Center in Missouri, is ranked among the top cancer facilities in the nation by U.S. News & World Report. Comprising the cancer research, prevention and treatment programs of Barnes-Jewish Hospital and Washington University School of Medicine, Siteman is also Missouri’s only member of the National Comprehensive Cancer Network.

About Barnes-Jewish Hospital
Barnes-Jewish Hospital is a 1,315 bed teaching hospital affiliated with Washington University School of Medicine in St. Louis, Mo. The hospital has a 1,763 member medical staff, with many recognized as "Best Doctors in America." Barnes-Jewish is a member of BJC HealthCare, which provides a full range of health care services through its 13 hospitals and more than 100 health care sites in Missouri and Illinois. Barnes-Jewish Hospital is also consistently ranked on the elite honor roll as one of America’s “Best Hospitals” by U.S. News & World Report.

About Washington University School of Medicine
Washington University School of Medicine’s 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children’s hospitals. The School of Medicine is one of the leading medical research, teaching and patient care institutions in the nation, currently ranked sixth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children’s hospitals, the School of Medicine is linked to BJC HealthCare.

Read the full story at http://www.prweb.com/releases/2013/12/prweb11438953.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Saving fertility not priority at most cancer centers
2. Fatigue, a common side effect of breast cancer treatment, evaluated in novel patient study
3. Ivy Foundation awards $3 million grant, supporting brain cancer research in Arizona
4. Diet rich in tomatoes may lower breast cancer risk
5. CNIO and Merck sign license agreement for the development of new cancer drugs
6. Cleveland Clinic receives grant to study role of DNA damage in treatment-resistant prostate cancer
7. HPV home tests could identify cancer risk
8. Colorectal Cancer Market Analysis and 2019 Forecasts in New Research Report at RnRMarketResearch.com
9. ABCD: After Breast Cancer Diagnosis Elects New Board Members, Adds New Staff
10. Pain drugs used in prostate gland removal linked to cancer outcome, Mayo Clinic-led study finds
11. Lung cancer death rates continue to fall, helping the decrease in overall cancer death rates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Vegas, Nevada (PRWEB) , ... February 08, 2016 ... ... at RowdMap, Inc., will be speaking on how healthcare companies can use newly ... costs, manage the health of a population and intervene and capture the value ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... four states in the U.S. require dental technicians to be certified or obtain ... dental industry, NADL created the “What’s In Your Mouth?” campaign to inform dentists ...
(Date:2/7/2016)... Texas (PRWEB) , ... February 07, 2016 , ... ... new MyDecision™ program. MyDecision™ empowers employers and organizations with the tools and information ... MyDecision™ combines three elements to cut the cost of providing employee healthcare benefits ...
(Date:2/6/2016)... ... 06, 2016 , ... US Sports Camps is proud to sponsor the Bay ... together top non-profit leaders, ultimate organizations, and coaches from around the US. The theme ... Disc Program Director of Youth and Education, describes this year YUCC as “an important ...
(Date:2/6/2016)... ... February 06, 2016 , ... Research has shown ... to reduce the frequency and level of relapse. , At the ... and Purpose,” will explore the critical tasks of the recovery phase and beyond ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... Alzheimer Diagnostic Tests - Medical Devices ... Devices sector report , "Alzheimer Diagnostic Tests - ... of Alzheimer Diagnostic Tests currently in pipeline stage. ... pipeline products with comparative analysis of the products ... major players involved in the pipeline product development. ...
(Date:2/8/2016)... 2016 CBG Technologies, a U.S. company, ... Recycling Systems, specifically designed for precision parts cleaning. ... and existing vapor degreasers, parts washers and ultrasonic ... continuous recycling and recovers 100% of the solvent ... --> Precision parts manufacturers benefit from this ...
(Date:2/8/2016)... --> --> ... Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, ... Ophthalmology, Gynecology) - Global Forecasts to 2020", published by ... forecast period of 2015 to 2020. The market is ... of 10.5% from 2015 to 2020. Browse ...
Breaking Medicine Technology: